CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-02). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1953 · Search date 2026-08-02 · Methodology v0.6

Whole lettuce,
does it really help with Reduced incidence of estrogen-receptor-negative breast cancer?

30-Second Summary
C
Evidence Grade C · 40 · Safety acceptable
The ER-negative association was small, unstable, and did not remain a lettuce-specific signal
Lettuce is generally safe in ordinary food amounts. Raw leaves should be washed thoroughly and refrigerated to reduce foodborne-infection risk.
What the
research shows
The grade is C. There is no randomized trial. In two nurse cohorts, each additional two weekly servings reported was associated with ER-negative breast-cancer HR 0.96 (95% CI 0.93 to 0.99), but about 30 individual fruits and vegetables were each tested across two subtypes, producing about 60 tests without multiplicity correction. Lettuce dropped out of the authors' own stepwise selection, leaving only carrots and winter squash. This small observational signal gives 40 points.
What the
ads claim
An association among people reporting more lettuce is not proof that assigning lettuce prevents cancer. This verdict concerns the whole food, not lettuce extract.
*

Useful facts when choosing a product

  • Lettuce follow-up began in 1984 because it was absent from the 1980 questionnaire; lettuce-specific person-time and cases were not reported.
  • Donguibogam and Shiliao Bencao said lettuce reduces sleep, while Dioscorides, Galen, Culpeper, and Evelyn said it induces sleep. These opposing traditional records concern sleep, not breast cancer.
  • Verdict 350 is C with 56 points for Heukharang lettuce extract and sleep; verdict 359 is ? for wild-lettuce extract. This is a different whole-food and cancer-incidence question.
Gap Measurement · Verdict 1953 · C 40
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Farvid and colleagues did not assign lettuce; they followed people who reported eating more of it in NHS and NHSII. Lettuce was absent from the 1980 questionnaire, so its follow-up began in 1984. The paper's overall 182,145 women and 1,794 ER-negative cases are not the lettuce-specific denominator, and lettuce-specific person-time and case counts were not reported. The ER-negative HR per two additional weekly servings was 0.96 (95% CI 0.93 to 0.99); ER-positive disease was 1.00 (0.98 to 1.01). About 30 individual fruits and vegetables were each tested across two receptor subtypes, producing about 60 tests without multiplicity correction; lettuce dropped out of the authors' own stepwise selection, leaving only carrots and winter squash. A 20-cohort pooled analysis of 993,466 people reported lettuce/salad RR 0.91 (0.84 to 0.98), but it included NHS-family data and overlapped in investigators, so it is not fully independent replication; its conclusion concerned overall produce rather than specific foods. No trial randomized lettuce intake. WHEL was neither a lettuce-only trial nor a primary-prevention trial in healthy people. It tested a multicomponent vegetable, fruit, fiber, and low-fat diet in breast-cancer survivors for recurrence and second primary cancers; its primary outcome was null, HR 0.96 (95% CI 0.80 to 1.14), p=0.63, but it is not a direct refutation trial of lettuce.

02

Why this is classified as C (40)

About 30 individual fruits and vegetables were each tested across two subtypes, producing about 60 tests without multiplicity correction, and lettuce dropped out of the authors' own stepwise selection while only carrots and winter squash remained. This is not a study without a notable bias defect; with no randomized lettuce trial and only a small cohort association, the grade is C with 40 points.

Counterpoint. The large prospective cohort and below-one confidence interval are acknowledged, but they cannot establish causality.

Rejudgment record. Cross-check applied — No randomized lettuce trial exists; the cohort association was small, uncorrected for multiple testing, and lettuce added no independent information in the authors' selection and total-vegetable models

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE~Statistically positive but below the threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Lower ER-negative breast-cancer incidenceCA small observational association that dropped out of variable selection.
Lower ER-positive breast-cancer incidenceDNull at HR 1.00 (0.98 to 1.01).
Randomized preventive effect of lettuce alone?No randomized trial assigned lettuce alone.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Prospective observational NHS and NHSII cohort analysis1,794Public US NIH fundingIncident ER-negative and ER-positive invasive breast cancerPer two additional weekly servings: ER-negative HR 0.96 (0.93 to 0.99); ER-positive 1.00 (0.98 to 1.01)Direct observational evidence, unstable under multiplicity and model selection
Study 2Randomized multicomponent-diet trial in breast-cancer survivors3,088US NIH and public fundingBreast-cancer recurrence or new primary cancerHR 0.96 (95% CI 0.80 to 1.14), p=0.63Not used as direct refutation because it was neither lettuce-only nor primary prevention in healthy people
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-08-02).

Farvid MS, Chen WY, Rosner BA, Tamimi RM, Willett WC, Eliassen AH. Fruit and vegetable consumption and breast cancer incidence. Int J Cancer. 2019;144(7):1496-1510. DOI: 10.1002/ijc.31653.
checked
Jung S, Spiegelman D, Baglietto L, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst. 2013;105(3):219-236. DOI: 10.1093/jnci/djs635.
checked
Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer. JAMA. 2007;298(3):289-298. DOI: 10.1001/jama.298.3.289.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-02 · Corrections: none

Cite this verdict

Whole lettuce x reduced ER-negative breast-cancer incidence Evidence Grade C card
[Chamgap] Whole lettuce x reduced ER-negative breast-cancer incidence — Evidence Grade C·40. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/womens/whole-lettuce-er-negative-breast-cancer-incidence/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.